International Journal of Pharmaceutical and Phytopharmacological Research
ISSN (Print): 2250-1029
ISSN (Online): 2249-6084
Publish with eIJPPR Submission
2025   Volume 15   Issue 6

Data Quality as a Bottleneck in AI-Driven Natural Product Discovery: Bias, Completeness, Assay Reliability, Chemical Annotation, and Model Generalizability
Download PDF


, ,
  1. Department of AI for Phytopharmaceutical Quality Control and Fingerprinting, Faculty of Pharmacy, University of Porto, Porto, Portugal.
  2. Department of Computational Metabolomics for Herbal Standardization, Faculty of Pharmaceutical Sciences, University of Campinas, Campinas, Brazil.
Citation
Vancouver
Santos V, Beatriz A, Dias J. Data Quality as a Bottleneck in AI-Driven Natural Product Discovery: Bias, Completeness, Assay Reliability, Chemical Annotation, and Model Generalizability. Int J Pharm Phytopharmacol Res. 2025;15(6):23-33. https://doi.org/10.51847/OfW9SyZSje
APA
Santos, V., Beatriz, A., & Dias, J. (2025). Data Quality as a Bottleneck in AI-Driven Natural Product Discovery: Bias, Completeness, Assay Reliability, Chemical Annotation, and Model Generalizability. International Journal of Pharmaceutical And Phytopharmacological Research, 15(6), 23-33. https://doi.org/10.51847/OfW9SyZSje
Download citation:   EndNote   RIS
Article Link:
Downloads: 24
Views: 69
Abstract

Artificial intelligence is increasingly used to support natural product discovery through structure-based prediction, bioactivity modeling, target inference, omics interpretation, ADMET estimation, toxicity prediction, and candidate prioritization. However, the reliability of these approaches depends on the quality of the chemical, biological, assay, source, and annotation data from which models learn. This article develops an original data quality framework for AI-driven natural product discovery. The framework treats data quality as a multidimensional bottleneck involving provenance, completeness, representativeness, assay reliability, chemical annotation, biological context, harmonization, leakage prevention, external validation, domain applicability, uncertainty communication, and auditability. Particular emphasis is placed on sampling bias, publication bias, database bias, missingness, class imbalance, label noise, conflicting records, incomplete metadata, assay variability, uncertain compound identity, stereochemical ambiguity, target annotation quality, and model generalizability. The central argument is that AI-driven natural product discovery is constrained not only by model architecture but also by the reliability, provenance, completeness, and domain relevance of the data used to train, validate, and interpret models. The proposed framework supports cautious research prioritization by defining quality-control gates across raw data, curated data, and model-ready datasets. It is conceptual rather than empirically validated and is intended to guide transparent dataset evaluation, model interpretation, and uncertainty-aware discovery workflows.

Related articles:
Most viewed articles:
Naproxen in Pain and Inflammation – A Review
Vol 11 Issue 1, 2021 | Svetoslav Nikolaev Stoev
An Overview on Emulgel
Vol 9 Issue 1, 2019 | Sreevidya V.S
Volume 16
Issue 1
2026

Call for Papers
[email protected]
Issues
Associations
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2026 International Journal of Pharmaceutical and Phytopharmacological Research
Authors retain copyright of their article if they are accepted for publication.